Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 14, 2014 - Issue 6
Submit an article Journal homepage
345
Views
16
CrossRef citations to date
0
Altmetric
Research Reports

Genomic profile of breast cancer: cost–effectiveness analysis from the Spanish National Healthcare System perspective

Miguel Ángel SeguíMedical Oncology Department, Corporació Sanitaria Parc Taulí, Sabadell, Spain
,
Carlos CrespoStatistical Department, University of Barcelona, Barcelona, Spain;Oblikue Consulting, Barcelona, Spain
,
Javier CortésMedical Oncology Department, Hospital Vall d’Hebron, Barcelona, Spain
,
Ana LluchMedical Oncology Department, Hospital Clínico, Valencia, Spain
,
Max BrosaStatistical Department, University of Barcelona, Barcelona, Spain
,
Virginia BecerraScientific Department, Ferrer, vda. Diagonal, 549, 08029 Barcelona, Spain
,
Sebastián Matias ChiavennaScientific Department, Ferrer, vda. Diagonal, 549, 08029 Barcelona, Spain
&
Alfredo GraciaScientific Department, Ferrer, vda. Diagonal, 549, 08029 Barcelona, SpainCorrespondence[email protected]
 show all
Pages 889-899 | Published online: 12 Sep 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Elena Galve-Calvo, Eva González-Haba, Joana Gostkorzewicz, Irene Martínez & Alejandro Pérez-Mitru. (2018) Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2− advanced or metastatic breast cancer in Spain. ClinicoEconomics and Outcomes Research 10, pages 773-790.
Read now
Juliette Plun-Favreau, Christer Svedman, William Valentine & Roman Rouzier. (2015) Genomic profile of breast cancer. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 393-394.
Read now

Articles from other publishers (14)

Leonardo Rojas, María X. Rojas-Reyes, Diego Rosselli, Juan Guillermo Ariza, Alejandro Ruiz-Patiño & Andrés F. Cardona. (2023) Cost-utility analysis of genomic profiling in early breast cancer in Colombia. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Ramona Erber, Miriam Angeloni, Robert Stöhr, Michael P. Lux, Daniel Ulbrich-Gebauer, Enrico Pelz, Agnes Bankfalvi, Kurt W. Schmid, Robert F. H. Walter, Martina Vetter, Christoph Thomssen, Doris Mayr, Frederick Klauschen, Peter Sinn, Karl Sotlar, Katharina Stering, Albrecht Stenzinger, Marius Wunderle, Peter A. Fasching, Matthias W. Beckmann, Oliver Hoffmann, Rainer Kimmig, Nadia Harbeck, Rachel Wuerstlein, Fulvia Ferrazzi & Arndt Hartmann. (2022) Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting. International Journal of Molecular Sciences 23:15, pages 8716.
Crossref
Lytske Bakker, Jos Aarts, Carin Uyl-de Groot & William Redekop. (2020) Economic evaluations of big data analytics for clinical decision-making: a scoping review. Journal of the American Medical Informatics Association 27:9, pages 1466-1475.
Crossref
Stuart J. Wright, William G. Newman & Katherine Payne. (2019) Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review. PharmacoEconomics 37:8, pages 1011-1027.
Crossref
Mariana Brandão, Noam Pondé & Martine Piccart-Gebhart. (2019) Mammaprint™: a comprehensive review. Future Oncology 15:2, pages 207-224.
Crossref
Andrea Nicolini, Paola Ferrari & Michael J. Duffy. (2018) Prognostic and predictive biomarkers in breast cancer: Past, present and future. Seminars in Cancer Biology 52, pages 56-73.
Crossref
R. Colomer, I. Aranda-López, J. Albanell, T. García-Caballero, E. Ciruelos, M. Á. López-García, J. Cortés, F. Rojo, M. Martín & J. Palacios-Calvo. (2017) Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clinical and Translational Oncology 20:7, pages 815-826.
Crossref
Shi-Yi WangWeixiong DangIlana RichmanSarah S. MougalianSuzanne B. EvansCary P. Gross. (2018) Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal. Journal of Clinical Oncology 36:16, pages 1619-1627.
Crossref
José Palacios Calvo, Joan Albanell, Federico Rojo, Eva Ciruelos, Ignacio Aranda-López, Javier Cortés, Tomás García-Caballero, Miguel Martín, María Ángeles López-García & Ramon Colomer. (2018) Consenso de la Sociedad Española de Anatomía Patológica y la Sociedad Española de Oncología Médica sobre biomarcadores en cáncer de mama. Revista Española de Patología 51:2, pages 97-109.
Crossref
E.J. Blok, E. Bastiaannet, W.B. van den Hout, G.J. Liefers, V.T.H.B.M. Smit, J.R. Kroep & C.J.H. van de Velde. (2018) Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe. Cancer Treatment Reviews 62, pages 74-90.
Crossref
M.J. Duffy, N. Harbeck, M. Nap, R. Molina, A. Nicolini, E. Senkus & F. Cardoso. (2017) Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). European Journal of Cancer 75, pages 284-298.
Crossref
Virginie Nerich, Sopany Saing, Eva Maria Gamper, Georg Kemmler, Franck Daval, Xavier Pivot & Bernhard Holzner. (2016) Cost–utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment 159:3, pages 407-424.
Crossref
J.A. López Ruiz, I. Zabalza Estévez & J.A. Mieza Arana. (2016) Breast cancer: Determining the genetic profile from ultrasound-guided percutaneous biopsy specimens obtained during diagnostic workups. Radiología (English Edition) 58:3, pages 214-220.
Crossref
J.A. López Ruiz, I. Zabalza Estévez & J.A. Mieza Arana. (2016) Cáncer de mama: determinación del perfil genético a partir de la biopsia percutánea ecoguiada diagnóstica. Radiología 58:3, pages 214-220.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.